Accomplishments for 2009

SCCF submits the Continuation in Part (CIP) containing all our experimental results with human pediatric sickle cell patients’ blood to the U.S. Patent Office, March 15, 2009. The U.S. Patent on our sickle cell cure is issued the following month, 4/14/09. SCCF’s patents in the U.S., Canada, Australia, and the European Union (U.K., France, Germany, [...]